Excited to share that I will be joining the Columbia Business School Executive Education module in #ManagingDTX #DigitalHealth #Strategy-- April 6-15th provided in a distance learning format, click here to learn more: www8.gsb.columbia.edu/execed/program… #ExecutiveEducation #HealthTech

Our next chapter begins today. We are pleased to announce we have entered into an agreement to become a public company through a business combination with the SPAC thimblepoint, which is expected to close in the second half of 2021. bit.ly/35JziUA #digitalhealth

Yes!

Katie Couric sits down with CEO Kevin Conroy to discuss our mission to eradicate cancer and how our teams are working to make it possible to detect cancers earlier. ms.spr.ly/6018Xgb4u Katie Couric

"we need to change the discussion from data privacy to data governance". Well said Andy Coravos - give users the tools to choose and decide not the rules to decide or protect on their behalves.

Come join our growing team of #digitalhealth #cancerfighters careers-exactsciences.icims.com/jobs/10942/ass…

Come join our growing team of #digitalhealth #cancerfighters careers-exactsciences.icims.com/jobs/10942/ass…

Countdown to HXD Conference #HXD2022. Very much looking fwd!

Amazing research from Ben Shneiderman presents framework to super-power human performance in healthcare with AI #HXD2022 hcil.umd.edu/human-centered…

Digital Phenotyping: using data from smart devices and wearables to personalize digital health interventions. A fascinating overview of recent progress and future opportunities. #digitalhealth #digitalphenotyping #wearables bioinform.jmir.org/2022/1/e39618

The field of Digital Therapeutics stands on the shoulders of giants, and it's been an absolute privilege to publish many of their perspectives in this edited volume.

We’re thrilled to announce results from BLUE-C, our pivotal trial to evaluate the performance of our next-generation Cologuard® test. The results show that the test met all study endpoints & improved on every top-line metric from Cologuard. Read more: exas.co/3pdSAyR

We’re excited to share our Q2 earnings. Read more about the strong results here: exas.co/44HsHXH

Many thanks again to our partners and friends at MAPS and at OM1 for hosting an exciting discussion on accelerating the translation of medical innovation with #realworlddata and #realworldevidence !

Today we announced our preliminary Q4 results. For more information, see our press release here: ms.spr.ly/6012ilyfm

Whoa! AllofUsResearch is hiring a Chief User Experience Officer, to lead all aspects of user-centered design! AllofUsResearch already has 535,000+ individuals (heading to 1 million+) contributing biospecimens & surveys… already one of the largest biomed cohorts in the world!

The New England Journal of Medicine has published results from BLUE-C, the pivotal trial evaluating the performance of our next-generation Cologuard® test. Read the press release: bit.ly/3vhkkWb NEJM